Abstract: Compositions and methods are provided for the treatment of obesity in a human in need of such treatment which comprises administration to the human of a therapeutically effective amount of a compound of a weight loss enhancing beta-3-adrenergic compound of Cycle I, and a different weight loss enhancing adenylate cyclase receptor replenishing compound of Cycle II, in conjunction with a pharmaceutically acceptable diluent or carrier, wherein the Compound of Cycle I and the compound of Cycle II are administered sequentially. The composition may be present as a kit having each sequence in blister packs.

Abstract: A new and unique innovation in the art of bead weaving on a loom by eliminating the numerous remaining ends of the warp threads which, in other methods, must be woven back into the finished project. The innovation results in having only two remaining warp threads instead of many. The innovation also provides a new method for adjustment of the project length through the use of a “floating” rear vertical upright tailstock.

Abstract: The present invention relates to novel ophthalmic pharmaceutical compositions comprising an inflammation-treating amount of a 4-aminoquinoline compound, derivative, isomers, or chemical salts, and methods for using these compositions for the treatment of ocular inflammatory conditions by topical administration directly to the eye.

Abstract: The present invention relates generally to a therapeutic device and related methods for treating arthritis of the knee. The therapeutic device includes a stretchable band having a predetermined length, a flexible and resilient body installed in the longitudinal middle of the stretchable band with a substantially triangular cross-section whose height is greater at one side of the stretchable band than at the other, such that the higher portion of the flexible and resilient body is applied to the sole at a position nearer to the inner or outer side thereof, and the stretchable band may be used to wrap and fix the ankle.